Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition

Somatic mutations in the isocitrate dehydrogenase (IDH) genes IDH1 and IDH2 occur frequently in acute myeloid leukemia (AML) and other cancers. These genes encode neomorphic proteins that produce the presumed oncometabolite 2-hydroxyglutarate (2-HG). Despite the prospect of treating AML and other ca...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chong Chen, Yu Liu, Chao Lü, Justin R. Cross, John P. Morris, Aditya Shroff, Patrick S. Ward, James E. Bradner, Craig B. Thompson, Scott W. Lowe
Médium: Artigo
Jazyk:angličtina
Vydáno: 2013
On-line přístup:https://doi.org/10.1101/gad.226613.113
http://genesdev.cshlp.org/content/27/18/1974.full.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!